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Introduction: High quality epidemic forecasting and prediction are critical to support response to local, regional
and global infectious disease threats. Other fields of biomedical research use consensus reporting guidelines to
ensure standardization and quality of research practice among researchers, and to provide a framework for endusers to interpret the validity of study results. The purpose of this study was to determine whether guidelines
exist specifically for epidemic forecast and prediction publications.
Methods: We undertook a formal systematic review to identify and evaluate any published infectious disease
epidemic forecasting and prediction reporting guidelines. This review leveraged a team of 18 investigators from
US Government and academic sectors.
Results: A literature database search through May 26, 2019, identified 1467 publications (MEDLINE n = 584,
EMBASE n = 883), and a grey-literature review identified a further 407 publications, yielding a total 1777
unique publications. A paired-reviewer system screened in 25 potentially eligible publications, of which two
were ultimately deemed eligible. A qualitative review of these two published reporting guidelines indicated that
neither were specific for epidemic forecasting and prediction, although they described reporting items which
may be relevant to epidemic forecasting and prediction studies.
Conclusions: This systematic review confirms that no specific guidelines have been published to standardize the
reporting of epidemic forecasting and prediction studies. These findings underscore the need to develop such
reporting guidelines in order to improve the transparency, quality and implementation of epidemic forecasting
and prediction research in operational public health.
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1. Introduction

(Cohen et al., 2016), and the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines (Anon, 2019e).
The development of these reporting guidelines has been shown to be
effective in improving the quality and clarity of academic publications.
As an example, reporting of clinical trials improved after the introduction of the CONSORT guidelines (Hopewell et al., 2012).
To our knowledge, no current reporting guideline exists for epidemic forecasting and prediction research. Development of a comprehensive epidemic forecasting and prediction research reporting guideline may ultimately lead to improvements in: i) the consistency of
reporting, ii) the reproducibility of results, iii) the quality of practice,
and iv) the transparency of research. Underscoring the need for such
reporting standardization, a recent evaluation of Zika epidemic forecasting and prediction studies found that there was substantial heterogeneity in the reporting of study methods, uncertainties (assessed
through reporting of uncertainty intervals), data, and other critical information (e.g. clear and accurate display of model output) which
would be needed to completely understand and replicate the work
(Kobres et al., 2019).
An essential first step in efforts to develop epidemic forecasting
reporting guidelines is performing a systematic review, which follows
reporting health-research guideline development best-practice (Moher
et al., 2010, Anon, 2019c). We therefore undertook a systematic review
to (i) identify all published epidemic forecasting or prediction reporting
guidelines; and (ii) qualitatively evaluate their strengths, limitations
and suitability of any guidelines found for the field of epidemic forecasting and prediction research.

Epidemic forecasting and prediction are a critical biomedical research enterprise with major public and global health relevance (Rivers
et al., 2019; Polonsky et al., 2019). Forecasting and prediction of epidemiological phenomena has offered critical insights into recent outbreaks, including those caused by Ebola virus, Zika virus, chikungunya
virus, and pandemic influenza viruses (Worden et al., 2019; Perkins
et al., 2016; Del Valle et al., 2018; Kobres et al., 2019; Keegan et al.,
2017; Nsoesie et al., 2014). During recent outbreaks of Ebola, for instance, modeling research has predicted short and longer term case
count trajectories (Worden et al., 2019), has estimated the impact of
violence on outbreak growth and control (Wannier et al., 2019), has
predicted the effectiveness of non-pharmaceutical and vaccine countermeasures (Merler et al., 2016), and has quantified the risk of international spread (Gomes et al., 2014).
While the terms ‘forecasting’ and ‘prediction’ are often conflated
and heterogeneously defined, forecasting research typically offers
quantitative statements about an event, outcome, or trend that has not
yet been observed, conditional on data that has been observed. In the
context of infectious disease epidemics, this often refers to short- to
mid-term projections of disease incidence, and related targets, such as
the timing of peak incidence. Such forecasts can predict epidemic
growth, spatial spread, peak and total case burden, mortality, and
morbidity in ways relevant to resource management (Rivers et al.,
2019; Kobres et al., 2019). The term ‘prediction’ is more broadly and
loosely used in epidemiological research, and may refer to models that
examine the mechanistic drivers of epidemiological characteristics,
such as human mobility, population immunity, contact patterns, public
health interventions and climatic factors (Perkins et al., 2016; Ewing
et al., 2017), as well as studies that estimate epidemiological characteristics with inherent forecasting value, such as R0 (Kobres et al.,
2019). Forecasting research often uses data from these and other covariates. Epidemic forecasting and prediction is not limited to pandemics, the approaches also enhance routine preparedness for seasonal
communicable diseases such as non-pandemic influenza and dengue
viruses (Reich et al., 2019; Spreco et al., 2018; Debellut et al., 2018;
Lauer et al., 2018; Lowe et al., 2018, 2017). In this manuscript, we refer
to this collective body of research as “epidemic forecasting and prediction research”.
Many fields of biomedical research use consensus reporting guidelines to promote standardization and improve quality of research
practice. These reporting guidelines also provide a framework for endusers to interpret the validity of such research approaches and findings.
The Enhancing the Quality and Transparency of Health Research
(EQUATOR) network refers to biomedical research reporting guidelines
as “simple, structured tools for health researchers to use while writing
manuscripts” (Anon, 2019a). Rather than providing guidance on how to
perform research, they enumerate what should be reported in publications to “ensure a manuscript can be, for example, understood by a
reader or replicated by a researcher” (Anon, 2019b). In the case of epidemic forecasting, such readers may include those in operational public
health (such as government health officials), epidemic model developers who may seek to reproduce or leverage the modeling methods
presented in other studies, or the mainstream media (reporting to the
general public on an epidemic). The EQUATOR consortium further
defines a reporting guideline as “a checklist, flow diagram, or structured
text to guide authors in reporting a specific type of research, developed using
explicit methodology” (Anon, 2019b). The latter emphasis on explicit
methodology for creating guidelines requires a structured, reproducible, consensus process that is specifically described a priori
(Moher et al., 2010). Prominent reporting guidelines include the Preferred Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) statement (Anon, 2019c), the Consolidating Standards of
Reporting Trials (CONSORT) statement (Anon, 2019d), the Standards
for Reporting of Diagnostic Accuracy Studies (STARD) guidelines

2. Materials and methods
We followed the PRISMA statement to conduct this systematic review (Table S1) (Anon, 2019c). An a priori systematic review protocol
was developed and agreed upon by the entire review team (n = 18)
made up of members from U.S. Government and academia before the
review commenced. Our protocol was not published in the International Prospective Register of Systematic Reviews (PROSPERO), but is
publicly available at https://github.com/cmrivers?tab=repositories
(Anon, 2019g).
2.1. Search strategy
MEDLINE and EMBASE electronic databases were searched through
May 26, 2019, using the following search ontology: “[epidemic OR
outbreak OR influenza OR Ebola OR Zika OR SARS OR Chikungunya
OR MERS OR pathogen OR pandemic OR virus OR viruses] AND
[forecasting OR prediction OR modeling OR modelling] AND guidelines”. This search ontology was not restricted to the title or abstract.
The pathogen-specific terms (e.g “Zika”, “virus”) were included to
capture recent major outbreaks and epidemics, but as Boolean [OR]
operators these would not have restricted the search to just these pathogens or pathogen-categories.
In order to identify the relevant grey literature: (i) leading experts in
the field of epidemic modeling and forecasting were contacted through
an epidemic model implementation working group, and (ii) the
EQUATOR website was reviewed for any existing epidemic forecasting
guidelines which had been published (Anon, 2019a).
2.2. Eligibility criteria
Our inclusion criterion consisted of any publication which proposes
a set of reporting guidelines for epidemic forecasting or prediction research. Our exclusion criteria were as follows:

• Non-communicable disease modeling reporting guidelines
• Publications which proposed how to perform epidemic modeling
studies (rather than how to report them)
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• Modeling reporting guidelines which were not specific to epidemic
forecasting and prediction
• Narrative review articles
• Perspective pieces
• Editorials
• Duplicate studies
• Descriptive or analytic epidemiological publications
• Clinical management or diagnostic guidelines

ultimately deemed eligible by the paired-reviewer consensus process
through full text review (Eddy et al., 2012; Field et al., 2014). A further
qualitative review of these eligible publications by Eddy et al. and Field
et al. found that they were both limited in their guideline specificity and
applicability to epidemic forecasting and prediction reporting (Eddy
et al., 2012; Field et al., 2014).
The first, by Eddy et al., includes a set of recommendations for
medical decision-making model transparency in 2012 (Eddy et al.,
2012). The major rationale for these guidelines offered by the authors is
that “trust and confidence are critical to the success of health care models”
and can be achieved with transparency and validation. These authors
derived the guidelines through an iterative, structured process with
individuals (model users and model developers) voting on draft recommendations, which were made available for further comment.
However, these recommendations stop short of formal guidelines, were
designed to be applicable to the broad category medical decisionmaking models, were not specifically tailored to epidemic forecasting,
and do not encompass all of the uses relevant to epidemics (such as
guidance on the reporting of prospective forecasts and their method of
validation or the documentation of the source of epidemic case count
data). Further, the recommendations cover both model reporting as
well as the conduct of model validation.
Nevertheless, several aspects of these recommendations were found
to be potentially relevant to epidemic forecasting and prediction research. The authors call for modeling results to be transparent with
sufficient non-technical documentation to be accessible to any interested reader. Items suggested to be included in the non-technical section included: the purpose of the model, the model data sources, study
funding sources, a graphical representation of the model components,
model inputs, model outputs, effects of uncertainty, the potential applications of the model, and limitations of its intended applications
(Eddy et al., 2012).
Eddy et al. also call for extended technical model documentation to
allow full replication by others with sufficient modeling expertise. Yet
they highlight the challenges of providing such technical documentation in full, including intellectual property concerns, dynamic changes
to the model components over time, and the need for appropriate expertise to interpret technical documentation (particularly model code)

2.3. Study screening and eligibility determination

Literature review results were divided and assigned to 10 unique
reviewer-pairs across 18 investigators from U.S. Government and academia. Both reviewers in each pair independently screened the titles
and abstracts for potential eligibility in a citation manager software.
The two reviewers came to a consensus if their screened-in article shortlists differed, and a third-party adjudicator decided if the pairs were
unable to reach a consensus on screening in articles. For articles that
made the second-round review (i.e. the screened-in studies), the reviewer-pairs repeated the screening and consensus process with the full
text of the article to determine eligibility. Reasons for excluding the
study/article were documented. A third independent reviewer adjudicated when reviewers were unable to reach a consensus on the final
eligibility of any study.
2.4. Data collection process and data items
Eligible articles were qualitatively described by the reviewer pair in
conjunction with a 3rd reviewer.
3. Results
Our literature database search identified 1467 publications
(MEDLINE n = 584, EMBASE n = 883). A search of the EQUATOR
website and discussions with experts identified a further 405 and 2
publications, respectively (Fig. 1). Of these 1777 unique publications,
25 were screened-in through the first review of title and abstract for
further consideration (Fig. 1). Two of those publications were

Fig. 1. PRISMA flow chart.
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(Eddy et al., 2012). The authors suggest work-around solutions such as
running code and providing model output to others upon request, and/
or making full technical model documentation available upon private
request rather than providing complete code in the public domain
(Eddy et al., 2012).
The second candidate guidelines by Field et al. are an extension of
the STROBE guidelines for molecular epidemiology and seek to “improve the reporting of studies and, in turn, to assist interpretation of the data
and increase understanding of what was actually done by researchers”
(Field et al., 2014). These guidelines, named ‘STROBE for Molecular
Epidemiology’ (STROME), are not explicitly aimed at epidemic forecasting and prediction research. Rather, they apply to a wide range of
molecular epidemiology studies ranging from descriptive clonal typing
to advanced phylodynamics (Field et al., 2014). Nevertheless, these
recommendations also offered several reporting items of potential relevance to epidemic forecasting. These relevant items include (i) explicit description of case definitions, (ii) documentation of sampling
methods, (iii) documentation of the study time frame, (iv) description
of data sources and related laboratory diagnostic methods, (v) description of missing data, (vi) documentation of relevant ethics approvals, (vii) evaluating consistency of findings between different lines
of evidence, (viii) description of the study objectives, and (ix) acknowledgement of case ascertainment bias and non-independence, if
present. The development of the STROME guidelines also followed a
structured, iterative process of guideline development. Consecutive
versions of the guidelines were circulated to reach a consensus on
content, and incorporated a range of stakeholders and complementary
expertise from multiple countries, fields, and sectors (Field et al., 2014).
In addition to the review of these two eligible articles, the screening
process of our systematic review noted several publications that sought
to standardize good practices for biomedical modeling conduct (more
broadly than forecasting and prediction). In 2011 the International
Society for Pharmacoeconomics and Outcomes Research and the
Society for Medical Decision Making (ISPOR-SMDM) Modeling Good
Research Practices Task Force generated a set of “optimal practices that
all models should strive toward” (Caro et al., 2012). This consortium
derived a series of modeling good practice recommendations covering
model conceptualization, event simulation, dynamic transmission
modeling, model parameter estimation and uncertainty analysis (Caro
et al., 2012). These were not eligible in our review because they pertain
to modeling practice rather than model reporting. However, they may
be of general interest to the epidemic modeling community and we cite
them here (Caro et al., 2012; Briggs et al., 2012; Pitman et al., 2012).
Similar modeling practice guidelines for health technology assessment
and disaster response modeling were also noted (Brandeau et al., 2009;
Dahabreh et al., 2008).

accompany non-English articles (Anon, 2020). A final limitation was
that we did not explicitly search for reporting guidelines which exist for
non-medical forecasting. For example, these may be a feature of
weather forecasting and indeed infectious disease forecasters have often
looked to the field of weather forecasting for lessons on how to best
implement their research (Viboud and Vespignani, 2019).
To redress the lack of appropriate reporting standards for epidemic
forecasting and prediction (Kobres et al., 2019), we have now launched
the Epidemic Forecasting and Reporting Guidelines (EPIFORGE) initiative (Anon, 2019f). The EPIFORGE initiative aims to develop guidance on how to report epidemic forecasting and prediction studies (not
how to perform such studies) (Anon, 2019f). Broadly, EPIFORGE aims to
improve the consistency of epidemic forecasting reporting, and thereby
forecasting reproducibility, quality, and transparency. The systematic
review presented here was an important step of the EPIFORGE process
as it confirms the lack of a suitable existing guideline to meet the needs
of this field (Moher et al., 2010). The results of this effort are expected
in Spring 2020, and the EPIFORGE reporting checklist development
process has so far examined items within the domains of reproducibility, transparency, validity, interpretability, funding and sponsorship.
Further, this systematic review has provided valuable reference
materials for the EPIFORGE guideline development process (Anon,
2019f). While not specific to epidemic forecasting, the model reporting
recommendations by Eddy et al. and Field et al. have prompted consideration of case definitions, laboratory methods, code sharing, study
time-frames, missing data, model applications, funding sources, model
structure, and bias in the evolving EPIFORGE guidelines (Eddy et al.,
2012; Field et al., 2014). The guideline development principles used by
Eddy et al. and Field et al. have also been adopted into the EPIFORGE
methods which use a structured, iterative consensus process (i.e. a
three-round Delphi process) across a range of model developers and
model users from multiple sectors and multiple countries. These
methods follow best-practice guidance for health research reporting
guideline development (Anon, 2019b; Moher et al., 2010). Such an
approach is critical to maximizing the quality, acceptability, and
eventual implementation of the final EPIFORGE recommendations and
improve the quality, transparency, and reproducibility of forecasting/
prediction practice. (Eddy et al., 2012; Field et al., 2014).
Disclaimer
The content is solely the responsibility of the authors and does not
necessarily represent the official views of NIGMS or the National
Institutes of Health. Material has been reviewed by the Walter Reed
Army Institute of Research. There is no objection to its presentation
and/or publication. The opinions or assertions contained herein are the
private views of the author, and are not to be construed as official, or as
reflecting true views of the Department of the Army or the Department
of Defense. The views expressed here are those of the authors and do
not necessarily reflect the official policy of the Department of Defense,
Department of the Army, U.S. Army Medical Department or the U.S.
Government. The findings and conclusions in this report are those of the
authors and do not necessarily represent the official position of the
Centers for Disease Control and Prevention.

4. Conclusions
While our systematic review identified two eligible manuscripts that
highlighted important features of modeling studies by consensus (Eddy
et al., 2012; Field et al., 2014), neither publication ultimately described
reporting guidelines specific to epidemic forecasting and prediction.
This systematic review, therefore, confirms that no published recommendations exist to standardize the reporting of epidemic forecasting and prediction studies. This is in contrast to multiple other
biomedical research fields which have clear standards in study reporting, many of which are endorsed and enforced by biomedical
journals (Anon, 2019a, h).
One potential limitation of this systematic review is that, while it
did include two databases (MEDLINE and EMBASE), it did not include
others such as the Web of Science or SciELO. Including this latter database in particular may have mitigated another limitation of performing searches with English search terms only, although we did not
restrict the MEDLINE and EMBASE database searches by language and
MEDLINE does identify English-translated abstracts which often
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